Neuromedical aims Papnet at added-value market
This article was originally published in Clinica
Executive Summary
Neuromedical Systems plans to market Papnet, its neural network Pap smear reader, as an added value service, when it goes on sale in the US on December 1st. "We envision added accuracy for which the patient or doctor would pay extra," says vice-president and medical director Laurie Mango.